Lista de obras -

Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non-ST Elevation Myocardial Infarction

artículo científico publicado en 2018

Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shock

artículo científico publicado en 2008

Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention

artículo científico publicado en 2015

Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris

artículo científico publicado en 2008

Clinical manifestation and prognosis of early versus late stent thrombosis of drug-eluting stents

scientific article published on 14 April 2009

Clinical outcomes according to symptom presentation in patients with acute myocardial infarction: Results from the FAST-MI 2010 registry.

artículo científico publicado en 2017

Clinical outcomes after implantation of small diameter (=2.5 mm) sirolimus- versus paclitaxel-eluting stents

artículo científico publicado en 2009

Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents

artículo científico publicado en 2009

Comparison of Ticagrelor Versus Prasugrel to Prevent Periprocedural Myonecrosis in Acute Coronary Syndromes.

artículo científico publicado en 2015

Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.

artículo científico publicado en 2009

Comparison of safety, efficacy, and outcome of successful versus unsuccessful percutaneous coronary intervention in "true" chronic total occlusions

artículo científico publicado en 2008

Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding

artículo científico publicado en 2013

Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive factors

artículo científico publicado en 2010

Dosing strategies for antiplatelet therapy in percutaneous coronary intervention.

artículo científico publicado en 2010

Etiology and Prognosis of Cardiogenic Shock in a Secondary Center without Surgical Back-Up

artículo científico publicado en 2019

Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty.

artículo científico publicado en 2009

High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes

artículo científico publicado en 2011

Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation.

artículo científico publicado en 2008

Impact of a 600-mg loading dose of clopidogrel on 30-day outcome in unselected patients undergoing percutaneous coronary intervention

artículo científico publicado en 2008

Impact of bivalirudin on in-hospital bleeding and six-month outcomes in octogenarians undergoing percutaneous coronary intervention.

artículo científico publicado en 2009

Impact of bivalirudin use on outcomes in nonagenarians undergoing percutaneous coronary intervention.

artículo científico publicado en 2009

Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome

artículo científico publicado en 2008

Impact of thrombus aspiration use for the treatment of stent thrombosis on early patient outcomes

artículo científico publicado en 2009

Incidence, predictors, and outcome of new, subsequent lesions treated with percutaneous coronary intervention in patients presenting with myocardial infarction.

artículo científico publicado en 2009

Intra-individual variability in clopidogrel responsiveness in coronary artery disease patients under long term therapy

artículo científico publicado en 2010

Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice

artículo científico publicado en 2009

Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents

artículo científico publicado en 2009

Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis

artículo científico publicado en 2009

Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy.

artículo científico publicado en 2009

Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery

artículo científico publicado en 2009

Prognostic value of hemoglobin A1C levels in patients with diabetes mellitus undergoing percutaneous coronary intervention with stent implantation

scientific article published on 01 July 2009

Prognostic value of procedure-related myocardial infarction according to the universal definition of myocardial infarction in saphenous vein graft interventions.

artículo científico publicado en 2009

Prognostic value of the Syntax score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease

artículo científico publicado en 2009

Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stents.

artículo científico publicado en 2009

Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents

scientific article published on 01 April 2011

Relation of body mass index to high on-treatment platelet reactivity and of failed clopidogrel dose adjustment according to platelet reactivity monitoring in patients undergoing percutaneous coronary intervention

artículo científico publicado en 2009

Relationship between platelet reactivity inhibition and non-CABG related major bleeding in patients undergoing percutaneous coronary intervention

artículo científico publicado en 2010

Reply: Adenosine plasma concentration increase by ticagrelor in patients with acute coronary syndrome: no cause for fear in clinical practice

artículo científico publicado en 2014

Requirement for emergent coronary artery bypass surgery following percutaneous coronary intervention in the stent era.

artículo científico publicado en 2009

Stent thrombosis in 2008: definition, predictors, prognosis and treatment.

artículo científico publicado en 2008

Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation

artículo científico publicado en 2009

Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome.

artículo científico publicado en 2013

Ticagrelor increases endothelial progenitor cell level compared to clopidogrel in acute coronary syndromes: A prospective randomized study

scientific article published on 31 March 2015

Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry).

artículo científico publicado en 2008

Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention

artículo científico publicado en 2019

Vascular brachytherapy for patients with drug-eluting stent restenosis.

artículo científico publicado en 2008

Lista de obras de

Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non-ST Elevation Myocardial Infarction

Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shock

Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention

Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris

Clinical manifestation and prognosis of early versus late stent thrombosis of drug-eluting stents

Clinical outcomes according to symptom presentation in patients with acute myocardial infarction: Results from the FAST-MI 2010 registry.

Clinical outcomes after implantation of small diameter (=2.5 mm) sirolimus- versus paclitaxel-eluting stents

Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents

Comparison of Ticagrelor Versus Prasugrel to Prevent Periprocedural Myonecrosis in Acute Coronary Syndromes.

Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.

Comparison of safety, efficacy, and outcome of successful versus unsuccessful percutaneous coronary intervention in "true" chronic total occlusions

Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding

Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive factors

Dosing strategies for antiplatelet therapy in percutaneous coronary intervention.

Etiology and Prognosis of Cardiogenic Shock in a Secondary Center without Surgical Back-Up

Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty.

High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes

Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation.

Impact of a 600-mg loading dose of clopidogrel on 30-day outcome in unselected patients undergoing percutaneous coronary intervention

Impact of bivalirudin on in-hospital bleeding and six-month outcomes in octogenarians undergoing percutaneous coronary intervention.

Impact of bivalirudin use on outcomes in nonagenarians undergoing percutaneous coronary intervention.

Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome

Impact of thrombus aspiration use for the treatment of stent thrombosis on early patient outcomes

Incidence, predictors, and outcome of new, subsequent lesions treated with percutaneous coronary intervention in patients presenting with myocardial infarction.

Intra-individual variability in clopidogrel responsiveness in coronary artery disease patients under long term therapy

Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice

Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents

Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis

Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy.

Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery

Prognostic value of hemoglobin A1C levels in patients with diabetes mellitus undergoing percutaneous coronary intervention with stent implantation

Prognostic value of procedure-related myocardial infarction according to the universal definition of myocardial infarction in saphenous vein graft interventions.

Prognostic value of the Syntax score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease

Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stents.

Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents

Relation of body mass index to high on-treatment platelet reactivity and of failed clopidogrel dose adjustment according to platelet reactivity monitoring in patients undergoing percutaneous coronary intervention

Relationship between platelet reactivity inhibition and non-CABG related major bleeding in patients undergoing percutaneous coronary intervention

Reply: Adenosine plasma concentration increase by ticagrelor in patients with acute coronary syndrome: no cause for fear in clinical practice

Requirement for emergent coronary artery bypass surgery following percutaneous coronary intervention in the stent era.

Stent thrombosis in 2008: definition, predictors, prognosis and treatment.

Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation

Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome.

Ticagrelor increases endothelial progenitor cell level compared to clopidogrel in acute coronary syndromes: A prospective randomized study

Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry).

Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention

Vascular brachytherapy for patients with drug-eluting stent restenosis.